VOLASTRA THERAPEUTICS
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability.
VOLASTRA THERAPEUTICS
Industry:
Biotechnology Life Science Medical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.volastratx.com
Total Employee:
11+
Status:
Active
Total Funding:
119 M USD
Technology used in webpage:
Google Maps Google Google Cloud Google Maps API Google Maps For Work
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Fluence Therapeutics
Fluence Therapeutics is a Biotechnology Therapeutics commercializing photodynamic therapy (PDT) for the treatment of psoriasis.
IconOVir Bio
IconOVir Bio is a preclinical-stage biotechnology company.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Prime Medicine
Prime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.
Teitur Trophics
Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.
TFC Therapeutics
TFC Therapeutics is a biotechnology company developing novel biologics to target and eliminate key drivers of cancer.
Vizgen
Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Polaris Partners
Polaris Partners investment in Series A - Volastra Therapeutics
Cornell University
Cornell University investment in Series A - Volastra Therapeutics
Droia Ventures
Droia Ventures investment in Series A - Volastra Therapeutics
Eli Lilly
Eli Lilly investment in Series A - Volastra Therapeutics
Catalio Capital Management
Catalio Capital Management investment in Series A - Volastra Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Volastra Therapeutics
Vida Ventures
Vida Ventures investment in Series A - Volastra Therapeutics
Meyer Ventures
Meyer Ventures investment in Series A - Volastra Therapeutics
Polaris Partners
Polaris Partners investment in Seed Round - Volastra Therapeutics
Droia Ventures
Droia Ventures investment in Seed Round - Volastra Therapeutics
Official Site Inspections
http://www.volastratx.com Semrush global rank: 4 M Semrush visits lastest month: 2.72 K
- Host name: 48.206.233.35.bc.googleusercontent.com
- IP address: 35.233.206.48
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Volastra Therapeutics"
Volastra - Short Circuiting Cancer's Chaos
Volastra seeks out partnerships and strategic deals that enhance and expand our existing capabilities with organizations that share our passion for advancing cutting edge science to …See details»
Our Team - Volastra
At Volastra, we are relentlessly committed to harnessing cutting-edge science to discover, develop and deliver novel therapies to patients. Our leadership team brings together expertise from diverse disciplines including drug discovery, …See details»
Charting Volastra’s R&D path - Volastra
Oct 4, 2021 · At Volastra, we have a strategic approach to R&D that we believe will bring the latest science to patients, faster. We see three critical pieces to our R&D strategy: A deeply …See details»
Volastra Therapeutics - Crunchbase Company Profile & Funding
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers. View contacts for Volastra Therapeutics to access new leads and connect …See details»
Volastra Company Profile 2024: Valuation, Funding & Investors
Operator of a drug discovery and therapeutics company intended to treat and prevent the formation of metastatic disease.See details»
Volastra Therapeutics - LinkedIn
Volastra Therapeutics | 3,491 followers on LinkedIn. Clinical stage biotech developing a powerful new class of cancer therapies exploiting chromosomal instability. | Volastra Therapeutics is a …See details»
Volastra Therapeutics - VentureRadar
Website: http://www.volastratx.com/ Develops clinical-stage drug discovery solutions targeting chromosomal instability in cancer treatment using proprietary CINtech platform and novel …See details»
Volastra - Overview, News & Similar companies | ZoomInfo.com
Mar 26, 2024 · View Volastra (www.volastratx.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
PATIENTS - Volastra
If you are a physician who is interested in learning more about our investigational therapies, or participating in our clinical trials, please submit a request to [email protected]. Volastra …See details»
Volastra Therapeutics Announces First Patient Dosed in Phase I/II ...
Oct 30, 2023 · VLS-1488 is a potent oral KIF18A inhibitor with the potential to be the first-ever chromosomal instability-targeted cancer therapy. Phase Ib trial for sovilnesib, Volastra’s …See details»
Volastra Therapeutics Extends Seed Financing to $44 Million to …
Apr 6, 2021 · NEW YORK-- ( BUSINESS WIRE )-- Volastra Therapeutics, a biotechnology company developing novel therapies for the prevention and treatment of metastatic cancer, …See details»
Volastra Company Profile | Management and Employees List
Volastra is a biotechnology company developing novel therapies to treat and prevent the formation of metastatic disease. Established in 2019, Volastra is headquartered in New York, …See details»
Volastra Therapeutics Announces New and Expanded Partnerships …
Mar 26, 2024 · Microsoft, Function Oncology and Tailor Bio collaborations will support the evolution of predictive biomarkers across a diversity of tumors. Identified biomarkers may …See details»
Judy O’Hagan - Volastra
Judy is currently the Principal Consultant at JOH Organizational Solutions, which she founded in 2016 to help companies with on Leadership Development, Organizational Development, and …See details»
Volastra Therapeutics Partners with Microsoft to Advance …
Apr 6, 2021 · Volastra Therapeutics is pioneering novel approaches to halt or prevent cancer metastasis, one of the major unsolved challenges in cancer treatment. Co-founders Lewis …See details»
Volastra Therapeutics - workinbiotech.com
Volastra Therapeutics is developing drugs that target a vulnerability of cancer cells - chromosomal instability, or CIN. CIN is present in 60-80% of cancers and is associated with poor survival in …See details»
Volastra Therapeutics Careers, Perks + Culture | Built In
Volastra Therapeutics, Inc. is a clinical stage oncology biotechnology company based in New York City. Founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento, Volastra is …See details»
Partnerships & Deals - Volastra
Volastra seeks out partnerships and strategic deals that enhance and expand our existing capabilities with organizations that share our passion for advancing cutting edge science to …See details»
Volastra Therapeutics, Inc. | Insights
Volastra Therapeutics has a goal to exploit chromosomal instability (CIN) – the process by which cancer cells divide and are able to evade the body’s normal responses – to develop a new …See details»
Volastra Therapeutics Granted FDA Fast Track Designation for …
NEW YORK – October 2, 2024 – Volastra Therapeutics, a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track …See details»